|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
intramuscular injection
|
|
gptkbp:approvedBy
|
gptkb:WHO
gptkb:FDA
gptkb:EMA
2020
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:boosters
|
yes
bivalent
monovalent
|
|
gptkbp:brand
|
gptkb:Comirnaty
gptkb:Spikevax
|
|
gptkbp:clinicalTrialPhase
|
Phase 3 completed
|
|
gptkbp:contains
|
messenger RNA
|
|
gptkbp:developedBy
|
gptkb:Moderna
gptkb:Pfizer-BioNTech
|
|
gptkbp:duration
|
wanes over time
|
|
gptkbp:effect
|
high against severe disease
reduced against some variants
|
|
gptkbp:eligiblePopulation
|
adults
children (age varies by country)
|
|
gptkbp:emergencyServices
|
granted in many countries
|
|
gptkbp:excludes
|
adjuvant
live virus
preservative
|
|
gptkbp:globalPresence
|
widespread
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
COVID-19 mRNA vaccines
|
|
gptkbp:notRecommendedFor
|
severe allergic reaction to vaccine ingredients
|
|
gptkbp:pregnancyCategory
|
generally considered safe
|
|
gptkbp:regulates
|
emergency use in others
full approval in some countries
|
|
gptkbp:requires
|
two doses (primary series)
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
muscle pain
anaphylaxis
chills
myocarditis
injection site pain
|
|
gptkbp:storage
|
gptkb:frozen_(Moderna)
gptkb:ultra-cold_(Pfizer-BioNTech)
|
|
gptkbp:target
|
gptkb:SARS-CoV-2_spike_protein
|
|
gptkbp:technology
|
lipid nanoparticle delivery
|
|
gptkbp:updatedForVariants
|
yes
|
|
gptkbp:usedFor
|
prevention of COVID-19
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
included
|
|
gptkbp:bfsParent
|
gptkb:Katalin_Karikó
|
|
gptkbp:bfsLayer
|
5
|